Thomas Vanassche

8.6k total citations
145 papers, 2.6k citations indexed

About

Thomas Vanassche is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Infectious Diseases. According to data from OpenAlex, Thomas Vanassche has authored 145 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Cardiology and Cardiovascular Medicine, 40 papers in Internal Medicine and 25 papers in Infectious Diseases. Recurrent topics in Thomas Vanassche's work include Atrial Fibrillation Management and Outcomes (54 papers), Venous Thromboembolism Diagnosis and Management (40 papers) and Antimicrobial Resistance in Staphylococcus (18 papers). Thomas Vanassche is often cited by papers focused on Atrial Fibrillation Management and Outcomes (54 papers), Venous Thromboembolism Diagnosis and Management (40 papers) and Antimicrobial Resistance in Staphylococcus (18 papers). Thomas Vanassche collaborates with scholars based in Belgium, United States and Netherlands. Thomas Vanassche's co-authors include Peter Verhamme, Laurens Liesenborghs, Marijke Peetermans, Christophe Vandenbriele, Marc Hoylaerts, John W. Eikelboom, Willy Peetermans, Olaf Schneewind, Jorien Claes and Jan Verhaegen and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Thomas Vanassche

136 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Vanassche Belgium	31	1.1k	646	610	515	393	145	2.6k
Michael Schwameis Austria	23	348 0.3×	126 0.2×	320 0.5×	309 0.6×	175 0.4×	96	1.6k
Jeanet M. Kemmeren Netherlands	21	354 0.3×	242 0.4×	185 0.3×	300 0.6×	233 0.6×	47	2.0k
Steven Vanderschueren Belgium	33	516 0.5×	231 0.4×	912 1.5×	1.3k 2.6×	1.0k 2.6×	135	4.5k
Pablo Maria Alberto Pomerantzeff Brazil	24	1.6k 1.4×	79 0.1×	300 0.5×	882 1.7×	793 2.0×	157	3.3k
Francis Zech Belgium	25	268 0.2×	214 0.3×	206 0.3×	853 1.7×	711 1.8×	84	3.1k
Charles F. Arkin United States	17	339 0.3×	237 0.4×	165 0.3×	280 0.5×	362 0.9×	38	1.8k
Carlo Bonfanti Italy	24	198 0.2×	227 0.4×	258 0.4×	430 0.8×	155 0.4×	90	1.8k
Michael Wernecke United States	21	798 0.7×	399 0.6×	263 0.4×	724 1.4×	70 0.2×	57	2.0k
Saskia Kuipers Netherlands	20	137 0.1×	330 0.5×	268 0.4×	311 0.6×	182 0.5×	42	1.1k
R Grillo Italy	15	1.3k 1.2×	129 0.2×	189 0.3×	1.4k 2.7×	1.0k 2.6×	52	3.4k

Countries citing papers authored by Thomas Vanassche

Since Specialization

Citations

This map shows the geographic impact of Thomas Vanassche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Vanassche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Vanassche more than expected).

Fields of papers citing papers by Thomas Vanassche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Vanassche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Vanassche. The network helps show where Thomas Vanassche may publish in the future.

Co-authorship network of co-authors of Thomas Vanassche

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Vanassche. A scholar is included among the top collaborators of Thomas Vanassche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Vanassche. Thomas Vanassche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fischerová, D., François Planchamp, Juan Luis Alcázar, et al.. (2025). ISUOG/ESGO Consensus Statement on ultrasound‐guided biopsy in gynecological oncology. Ultrasound in Obstetrics and Gynecology. 65(4). 517–535. 1 indexed citations

Geet, Chris Van, Peter Verhamme, Thomas Vanassche, et al.. (2025). Clinical utility of panel-based genetic sequencing for von Willebrand disease. Research and Practice in Thrombosis and Haemostasis. 9(2). 102730–102730. 2 indexed citations

Peetermans, Marijke, et al.. (2023). Peptidylarginine deiminase 4 and ADAMTS13 activity in Staphylococcus aureus bacteraemia. Philosophical Transactions of the Royal Society B Biological Sciences. 378(1890). 20230042–20230042. 6 indexed citations

Vanassche, Thomas, et al.. (2023). Therapy and guideline adherence at a multidisciplinary hypertension clinic: A prospective, observational study. Vascular Pharmacology. 154. 107271–107271. 1 indexed citations

Wei, Dongmei, Jesús D. Melgarejo, Lucas Van Aelst, et al.. (2023). Prediction of coronary artery disease using urinary proteomics. European Journal of Preventive Cardiology. 30(14). 1537–1546. 11 indexed citations

Dreesen, Erwin, Thomas Vanassche, Peter Verhamme, et al.. (2023). Insights into the Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Older Adults with Atrial Fibrillation: A Structured Narrative Review. Clinical Pharmacokinetics. 62(3). 351–373. 8 indexed citations

Jacquemin, Marc, Veerle Labarque, Chantal Thys, et al.. (2023). Clinical application of multigene panel testing for bleeding, thrombotic, and platelet disorders: a 3-year Belgian experience. Journal of Thrombosis and Haemostasis. 21(4). 887–895. 13 indexed citations

Jong, Cindy M.M. de, Marc Blondon, Cihan Ay, et al.. (2022). Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism. Blood. 140(16). 1764–1773. 22 indexed citations

Martens, Pieter, Chantal Mathieu, & Thomas Vanassche. (2022). The use of glucagon-like-peptide-1 receptor agonist in the cardiology practice. Acta cardiologica. Supplementum. 78(5). 552–564. 3 indexed citations

10.

Ockerman, Anna, Maarten Vanhaverbeke, Thomas Vanassche, et al.. (2021). Tranexamic acid and bleeding in patients treated with non-vitamin K oral anticoagulants undergoing dental extraction: The EXTRACT-NOAC randomized clinical trial. PLoS Medicine. 18(5). e1003601–e1003601. 12 indexed citations

11.

Barco, Stefano, Serena Granziera, Michiel Coppens, et al.. (2019). Determinants of the Quality of Warfarin Control after Venous Thromboembolism and Validation of the SAMe-TT2-R2 Score: An Analysis of Hokusai-VTE. Thrombosis and Haemostasis. 119(4). 675–684. 6 indexed citations

12.

Peetermans, Marijke, Severien Meyers, Laurens Liesenborghs, et al.. (2019). Von Willebrand factor and ADAMTS13 impact on the outcome of Staphylococcus aureus sepsis. Journal of Thrombosis and Haemostasis. 18(3). 722–731. 29 indexed citations

13.

Jacquemin, Marc, Jaan Toelen, Luc Feyen, et al.. (2018). The adsorption of dabigatran is as efficient as addition of idarucizumab to neutralize the drug in routine coagulation assays. International Journal of Laboratory Hematology. 40(4). 442–447. 30 indexed citations

14.

Brekelmans, Marjolein, Walter Ageno, Ludo F.M. Beenen, et al.. (2016). Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study. The Lancet Haematology. 3(9). e437–e445. 25 indexed citations

15.

Bosch, Jackie, et al.. (2015). Global Survey of the Diagnostic Evaluation and Management of Cryptogenic Ischemic Stroke. International Journal of Stroke. 10(7). 1031–1036. 41 indexed citations

16.

Jacquemin, Marc, Jaan Toelen, I. Vanlinthout, et al.. (2015). The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disorders. Journal of Thrombosis and Haemostasis. 13(11). 2087–2092. 35 indexed citations

17.

Peetermans, Marijke, et al.. (2014). Monitoring and reversal strategies for new oral anticoagulants. Expert Review of Cardiovascular Therapy. 13(1). 95–103. 29 indexed citations

18.

Vanassche, Thomas, Stuart J. Connolly, John W. Eikelboom, et al.. (2014). Abstract 18936: Can Biomarkers Improve Risk Stratification of Atrial Fibrillation Patients? Analysis of 3578 Aspirin-treated Patients in ACTIVE and AVERROES. Circulation. 130. 2 indexed citations

19.

Bosch, Jackie, et al.. (2014). Global Survey of the Diagnostic Evaluation and Management of Cryptogenic Ischemic Stroke. Stroke. 45(12).

20.

Vanassche, Thomas, Marijke Peetermans, Jan Verhaegen, et al.. (2011). Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus adhesion to catheter and other foreign surfaces in vitro and abscess volume in vivo. Journal of Thrombosis and Haemostasis. 9. 505–505. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact